Merck to register Gilead AIDS pill in poor countries

“Drug giant Merck & Co. plans to begin selling the three-in-one AIDS pill developed with Gilead Sciences Inc. in poor countries with high rates of HIV infection. Whitehouse Station, N.J.-based Merck will set the price of the pill on a sliding scale based on how poor a country is and how many of its population are infected with HIV. The tablet combines three drugs in one pill — Viread and Emtriva from Gilead, and Sustiva from Bristol-Myers Squibb Co. Foster City-based Gilead agreed to the low-cost sales in poor countries in August. Under that deal, Gilead will make the pills, while Merck will distribute them.”

San Francisco Business Times